Stoke Therapeutics (STOK) Depreciation and Depletion (2022 - 2025)

Stoke Therapeutics has reported Depreciation and Depletion over the past 4 years, most recently at $435000.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 17.3% year-over-year to $435000.0; the TTM value through Dec 2025 reached $1.8 million, down 17.32%, while the annual FY2025 figure was $1.8 million, 17.32% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $435000.0 at Stoke Therapeutics, down from $442000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $637000.0 in Q3 2023 and troughed at $247000.0 in Q1 2022.
  • A 4-year average of $496625.0 and a median of $533000.0 in 2024 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: soared 141.7% in 2023 and later decreased 18.61% in 2025.
  • Year by year, Depreciation and Depletion stood at $563000.0 in 2022, then rose by 10.83% to $624000.0 in 2023, then decreased by 15.71% to $526000.0 in 2024, then decreased by 17.3% to $435000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for STOK at $435000.0 in Q4 2025, $442000.0 in Q3 2025, and $446000.0 in Q2 2025.